A general anaesthetic propofol inhibits aquaporin-4 in the presence of Zn2+

Jungo Kato, Mariko Kato Hayashi, Shinnosuke Aizu, Yoshinori Yukutake, Junzo Takeda, Masato Yasui

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

AQP4 (aquaporin-4), a water channel protein that is predominantly expressed in astrocyte end-feet, plays an important role in the brain oedema formation, and is thereby considered to be a potential therapeutic target. Using a stopped-flow analysis, we showed that propofol (2,6-diisopropylphenol), a general anaesthetic drug, profoundly inhibited the osmotic water permeability of AQP4 proteoliposomes in the presence of Zn2+ . This propofol inhibition was not observed in AQP1, suggesting the specificity for AQP4. In addition, the inhibitory effects of propofol could be reversed by the removal of Zn2+ . Other lipid membrane fluidizers also similarly inhibited AQP4, suggesting that themodulation of protein-lipid interactions plays an essential role in the propofol-induced inhibition of AQP4. Accordingly, we used Blue native PAGE and showed that the profound inhibition caused by propofol in the presence of Zn2+ is coupled with the reversible clustering of AQP4 tetramers. Site-directed mutagenesis identified that Cys253, located at the membrane interface connecting to the C-terminal tail, is responsible for Zn2+ -mediated propofol inhibition. Overall, we discovered that propofol specifically and reversibly inhibits AQP4 through the interaction between Zn2+ and Cys253. The findings provide new insight into the functional regulation of AQP4 and may facilitate the identification of novel AQP4-specific inhibitors.

Original languageEnglish
Pages (from-to)275-282
Number of pages8
JournalBiochemical Journal
Volume454
Issue number2
DOIs
Publication statusPublished - 2013 Sep 1

Fingerprint

Aquaporin 4
General Anesthetics
Propofol
Native Polyacrylamide Gel Electrophoresis
Mutagenesis
Aquaporins
Brain Edema
Membrane Lipids
Site-Directed Mutagenesis
Astrocytes
Cluster Analysis
Anesthetics
Permeability
Brain
Membranes
Lipids

Keywords

  • Aquaporin 4 (AQP4)
  • Brain oedema
  • General anaesthetic
  • Water channel

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

A general anaesthetic propofol inhibits aquaporin-4 in the presence of Zn2+. / Kato, Jungo; Hayashi, Mariko Kato; Aizu, Shinnosuke; Yukutake, Yoshinori; Takeda, Junzo; Yasui, Masato.

In: Biochemical Journal, Vol. 454, No. 2, 01.09.2013, p. 275-282.

Research output: Contribution to journalArticle

Kato, Jungo ; Hayashi, Mariko Kato ; Aizu, Shinnosuke ; Yukutake, Yoshinori ; Takeda, Junzo ; Yasui, Masato. / A general anaesthetic propofol inhibits aquaporin-4 in the presence of Zn2+. In: Biochemical Journal. 2013 ; Vol. 454, No. 2. pp. 275-282.
@article{de773fd9306848b69666e176122c0e90,
title = "A general anaesthetic propofol inhibits aquaporin-4 in the presence of Zn2+",
abstract = "AQP4 (aquaporin-4), a water channel protein that is predominantly expressed in astrocyte end-feet, plays an important role in the brain oedema formation, and is thereby considered to be a potential therapeutic target. Using a stopped-flow analysis, we showed that propofol (2,6-diisopropylphenol), a general anaesthetic drug, profoundly inhibited the osmotic water permeability of AQP4 proteoliposomes in the presence of Zn2+ . This propofol inhibition was not observed in AQP1, suggesting the specificity for AQP4. In addition, the inhibitory effects of propofol could be reversed by the removal of Zn2+ . Other lipid membrane fluidizers also similarly inhibited AQP4, suggesting that themodulation of protein-lipid interactions plays an essential role in the propofol-induced inhibition of AQP4. Accordingly, we used Blue native PAGE and showed that the profound inhibition caused by propofol in the presence of Zn2+ is coupled with the reversible clustering of AQP4 tetramers. Site-directed mutagenesis identified that Cys253, located at the membrane interface connecting to the C-terminal tail, is responsible for Zn2+ -mediated propofol inhibition. Overall, we discovered that propofol specifically and reversibly inhibits AQP4 through the interaction between Zn2+ and Cys253. The findings provide new insight into the functional regulation of AQP4 and may facilitate the identification of novel AQP4-specific inhibitors.",
keywords = "Aquaporin 4 (AQP4), Brain oedema, General anaesthetic, Water channel",
author = "Jungo Kato and Hayashi, {Mariko Kato} and Shinnosuke Aizu and Yoshinori Yukutake and Junzo Takeda and Masato Yasui",
year = "2013",
month = "9",
day = "1",
doi = "10.1042/BJ20130046",
language = "English",
volume = "454",
pages = "275--282",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - A general anaesthetic propofol inhibits aquaporin-4 in the presence of Zn2+

AU - Kato, Jungo

AU - Hayashi, Mariko Kato

AU - Aizu, Shinnosuke

AU - Yukutake, Yoshinori

AU - Takeda, Junzo

AU - Yasui, Masato

PY - 2013/9/1

Y1 - 2013/9/1

N2 - AQP4 (aquaporin-4), a water channel protein that is predominantly expressed in astrocyte end-feet, plays an important role in the brain oedema formation, and is thereby considered to be a potential therapeutic target. Using a stopped-flow analysis, we showed that propofol (2,6-diisopropylphenol), a general anaesthetic drug, profoundly inhibited the osmotic water permeability of AQP4 proteoliposomes in the presence of Zn2+ . This propofol inhibition was not observed in AQP1, suggesting the specificity for AQP4. In addition, the inhibitory effects of propofol could be reversed by the removal of Zn2+ . Other lipid membrane fluidizers also similarly inhibited AQP4, suggesting that themodulation of protein-lipid interactions plays an essential role in the propofol-induced inhibition of AQP4. Accordingly, we used Blue native PAGE and showed that the profound inhibition caused by propofol in the presence of Zn2+ is coupled with the reversible clustering of AQP4 tetramers. Site-directed mutagenesis identified that Cys253, located at the membrane interface connecting to the C-terminal tail, is responsible for Zn2+ -mediated propofol inhibition. Overall, we discovered that propofol specifically and reversibly inhibits AQP4 through the interaction between Zn2+ and Cys253. The findings provide new insight into the functional regulation of AQP4 and may facilitate the identification of novel AQP4-specific inhibitors.

AB - AQP4 (aquaporin-4), a water channel protein that is predominantly expressed in astrocyte end-feet, plays an important role in the brain oedema formation, and is thereby considered to be a potential therapeutic target. Using a stopped-flow analysis, we showed that propofol (2,6-diisopropylphenol), a general anaesthetic drug, profoundly inhibited the osmotic water permeability of AQP4 proteoliposomes in the presence of Zn2+ . This propofol inhibition was not observed in AQP1, suggesting the specificity for AQP4. In addition, the inhibitory effects of propofol could be reversed by the removal of Zn2+ . Other lipid membrane fluidizers also similarly inhibited AQP4, suggesting that themodulation of protein-lipid interactions plays an essential role in the propofol-induced inhibition of AQP4. Accordingly, we used Blue native PAGE and showed that the profound inhibition caused by propofol in the presence of Zn2+ is coupled with the reversible clustering of AQP4 tetramers. Site-directed mutagenesis identified that Cys253, located at the membrane interface connecting to the C-terminal tail, is responsible for Zn2+ -mediated propofol inhibition. Overall, we discovered that propofol specifically and reversibly inhibits AQP4 through the interaction between Zn2+ and Cys253. The findings provide new insight into the functional regulation of AQP4 and may facilitate the identification of novel AQP4-specific inhibitors.

KW - Aquaporin 4 (AQP4)

KW - Brain oedema

KW - General anaesthetic

KW - Water channel

UR - http://www.scopus.com/inward/record.url?scp=84881523690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881523690&partnerID=8YFLogxK

U2 - 10.1042/BJ20130046

DO - 10.1042/BJ20130046

M3 - Article

C2 - 23772702

AN - SCOPUS:84881523690

VL - 454

SP - 275

EP - 282

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -